Viral Oncology Therapies

This feed focuses on Viral Oncology Therapies, which exploits the ability of genetically engineered viruses to infect and kill cancer cells. Discover the latest research on Viral Oncology Therapies here.

January 10, 2021

Development of New Oncolytic Virotherapy Targeting Breast Cancer Using Coxsackievirus B3

Anticancer Research
Miyako SagaraKenzaburo Tani
November 14, 2020
Open Access

Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells

Research in Veterinary Science
Keigo IizukaChieko Kai
January 16, 2021

Ultrasound-guided Intralesional Injection of Talimogene laherparepvec (Imlygic) for Advanced Melanoma: Technical Note on a Preliminary Experience

Cardiovascular and Interventional Radiology
Lauren M B BurkeFrances Collichio
December 15, 2020
Open Access

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

Acta Neuropathologica Communications
Ming LiHiroaki Wakimoto
January 5, 2021

Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer

Current Opinion in Urology
Lee A HugarRoger Li
December 20, 2020
Preprint
Open Access

Analysis of PPI networks of transcriptomic expression identifies hub genes Associated with Newcastle disease virus persistent infection in bladder cancer

BioRxiv : the Preprint Server for Biology
U. AhmadAbhi Veerakumarasivam
January 5, 2021
Open Access

Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation

Nanotheranostics
Mariangela GarofaloPaolo Ciana
December 17, 2020

Merits of the "Good" Viruses: The Potential of Virus-based Therapeutics

Expert Opinion on Biological Therapy
Qianyu ZhangXuefeng Xia
January 6, 2021
Review
Open Access

Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity

Cancers
Mohit KumarSakthivel Sadayappan
December 22, 2020

Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment

Molecular Therapy : the Journal of the American Society of Gene Therapy
Motomu NakatakeTakafumi Nakamura
December 19, 2020
Open Access

Suppression of CCDC6 sensitizes tumor to oncolytic virus M1

Neoplasia : an International Journal for Oncology Research
Ying LiuCheng Hu
January 15, 2021
Open Access

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

Nature Communications
Matthias GromeierDavid M Ashley
January 16, 2021
Review
Open Access

Clinical Trials in Metastatic Uveal Melanoma: Current Status

Ocular Oncology and Pathology
Tamara A SussmanArun Singh

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biosensor Development & Applications

Biosensor development and applications describe recent progress in biosensor development and their applications in the field of antibiotics and metabolic engineering. Discover the latest research on biosensor development and applications in this feed.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

© 2021 Meta ULC. All rights reserved
/feed-previews/viral-oncology-therapies/5341abd5-168b-43c2-be79-b72ee169b1a5